nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
您当前所在位置: 首页> 文献列表> 布地奈德氧气雾化吸入对慢阻肺急性发作期患者胸肺顺应性及气体交换参数的影响观察
2013, 08, v.19 1146-1148+1152
布地奈德氧气雾化吸入对慢阻肺急性发作期患者胸肺顺应性及气体交换参数的影响观察
基金项目(Foundation): 中国高校医学期刊临床专项资金项目(112210767)~~
邮箱(Email):
DOI: 10.13210/j.cnki.jhmu.2013.08.015
发布时间: 2013-04-19
出版时间: 2013-04-19
网络发布时间: 2013-04-19
移动端阅读
摘要:

目的:观察分析布地奈德氧气雾化吸入对慢阻肺急性发作期患者的影响,以了解其在改善患者胸肺顺应性及气体交换方面的作用。方法:选取2011年11月~2013年2月于本院进行常规治疗的41例慢阻肺急性发作期患者为对照组,并选取同期在常规治疗基础上加用布地奈德氧气雾化吸入治疗的41例患者为观察组,然后将两组患者治疗前与治疗后3d、5d的胸肺顺应性、肺通气及呼吸参数进行比较。结果:观察组治疗后3d、5d的胸肺顺应性、肺通气及呼吸参数改善幅度均大于对照组,并且观察组治疗后3d与5d的均好于治疗前,P均<0.05,均有显著性差异。结论:布地奈德氧气雾化吸入可有效改善慢阻肺急性发作期患者呼吸应答,因此对患者的低氧状态发挥出积极的改善作用。

Abstract:

Objective: To observe and analyze the influence of budesonide inhalation by oxygen atomizing to lung and thorax compliance and air exchange indexes of patients at acute stage of COPD.Methods:A total of 41 patients at acute stage of COPD that were treated with conventional therapy in our hospital from November 2011 to February 2013 were selected as control group,41 patients treated with conventional therapy and budesonide inhalation by oxygen atomizing were selected as observation group,then the thorax compliance,pulmonary ventilation and respiratory parameters of two groups before the treatment and 3 and 5 days after treatment were compared.Results:The improvement of thorax compliance,pulmonary ventilation and respiratory parameters of observation group 3 and 5 days after treatment were significant better than that before the treatment(P<0.05).Conclusion:The budesonide inhalation by oxygen atomizing can effectively improve the respiratory response of patients at acute stage of COPD,so it plays an active role in improving the hypoxia state and patients.

参考文献

1肖斌.吸入用布地奈德混悬液和异丙托溴铵溶液雾化吸入治疗慢性阻塞性肺疾病急性加重期疗效分析[J].中国社区医师:医学专业,2011,13(5):48.

2何莲.布地奈德、可必特联合压缩雾化吸入治疗慢阻肺急性发作疗效观察[J].临床肺科杂志,2010,15(11):1654-1655.

3欧阳修河,于立萍,郑文涛,等.慢阻肺急性发作期布地奈德雾化吸入的疗效与安全性评价[J].中国临床医学,2007,14(1):64-66.

4徐向玉.布地奈德与氨溴索雾化吸入对慢阻肺急性发作的治疗效果及护理[J].海峡药学,2012,24(11):114-116.

5尚晓霞,刘金丽,李佳等.呼吸康复对慢性阻塞性肺疾病患者肺功能改善的临床观察[J].实用心脑肺血管病杂志,2012,20(4):635.

6岳燕军,董存元,陈素娟.生脉注射液对慢阻肺发作期患者血清BNP、肺功能及氧代谢的影响[J].海南医学,2013,24(2):225-227.

7杨莉.氧气驱动联合药物治疗慢阻肺急性发作86例临床分析[J].中国医药指南,2012,10(18):180.

8 Briones Claudett KH,Briones Claudett M,Chung SangWong M,et al.Noninvasive mechanical ventilation withaverage volume assured pressure support(AVAPS)inpatients with chronic obstructive pulmonary disease andhypercapnic encephalopathy[J].BMC Pulm Med,2013,13(1):12.

9陈倩,安晓洁,陈峰,等.盐酸氨溴索注射液静脉滴注联合硫酸沙丁胺醇和布地奈德雾化吸入治疗慢性阻塞性肺疾病急性加重的疗效观察[J].中国全科医学,2012,15(17):1990-1992.

10雷蕾,吴昌归,张亮.布地奈德在慢性阻塞性肺疾病急性加重期的临床疗效观察[J].实用临床医药杂志,2010,14(23):14-17.

11杨金荣,郑晓燕,沈建英,等.布地奈德联合特布他林、异丙托溴胺雾化吸入治疗慢性阻塞性肺病急性加重期的临床疗效[J].南方医科大学学报,2010,30(11):2590-2591.

12刘军强,张浩飞.布地奈德雾化吸入治疗慢性阻塞性肺疾病加重期疗效分[J].昆明医学院学报,2011,32(5):165-166.

13高兴华,黄剑.甲泼尼龙静脉推注联合氨溴索、布地奈德雾化吸入治疗慢性阻塞性肺疾病急性加重期的效果观察[J].解放军医药杂志,2012,24(4):34-36.

14唐炳俭.普米克令舒万托林与爱全乐雾化吸入治疗慢阻肺急性加重期分析[J].中国卫生产业,2012,9(15):69.

15Zarowitz BJ,O'Shea T.Chronic obstructive pulmonary disease:prevalence,characteristics,and pharmacologic treatment in nursing home residents with cognitive im-pairment[J].J Manag Care Pharm,2012,18(8):598-606.

16李乾兵,陈俊,童亚玲.氨溴索对慢阻肺急性加重期患者呼吸和免疫功能的影响[J].皖南医学院学报,2009,28(5):339-341.

基本信息:

DOI:10.13210/j.cnki.jhmu.2013.08.015

中图分类号:R563.9

引用信息:

[1]唐友平.布地奈德氧气雾化吸入对慢阻肺急性发作期患者胸肺顺应性及气体交换参数的影响观察[J].海南医学院学报,2013,19(08):1146-1148+1152.DOI:10.13210/j.cnki.jhmu.2013.08.015.

基金信息:

中国高校医学期刊临床专项资金项目(112210767)~~

发布时间:

2013-04-19

出版时间:

2013-04-19

网络发布时间:

2013-04-19

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文